![]() |
½ÃÀ庸°í¼
»óǰÄÚµå
1348458
¼¼°èÀÇ ¼öÇ÷ ½ÃÀå : ±Ô¸ð, Á¡À¯À², µ¿Ç⠺м®(2024-2030³â) - MedCoreBlood Transfusion Market Size, Share & Trends Analysis | Global | 2024-2030 | MedCore |
2023³â ¼¼°èÀÇ ¼öÇ÷(Blood Transfusion) ½ÃÀå ±Ô¸ð´Â 2022³â ´ëºñ 3.5% °¨¼ÒÇß½À´Ï´Ù. ±×·¯³ª ÇâÈÄ Àü¸ÁÀº ¿¬Æò±Õ ¼ºÀå·ü(CAGR) 3.0%·Î ±àÁ¤ÀûÀÎ ¼ºÀå ±Ëµµ¸¦ ±×¸®¸ç ±Ã±ØÀûÀ¸·Î 5¾ï 9,100¸¸ ´Þ·¯¿¡ À̸¦ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù. ÇöÀç ¼¼°èÀÇ ¼öÇ÷ ½ÃÀåÀº Becton Dickinson(BD), Baxter, ICU MedicalÀÌ µ¶Á¡Çϰí ÀÖ½À´Ï´Ù.
¾Ï, ½ÉÇ÷°ü Áúȯ, Ç÷¾× Áúȯ µî ¸¸¼º ÁúȯÀÇ À¯º´·üÀº Áõ°¡ÇÏ´Â °æÇâÀÌ ÀÖÀ¸¸ç, Ä¡·áÀÇ Áß¿äÇÑ Ãø¸éÀ¸·Î Á¤±âÀûÀÎ ¼öÇ÷ÀÇ Çʿ伺ÀÌ Áõ°¡Çϰí ÀÖ½À´Ï´Ù. ÀÌ·¯ÇÑ Áúº´ÀÇ ÀÌȯÀ²ÀÌ Áõ°¡ÇÔ¿¡ µû¶ó ¼öÇ÷¿¡ ´ëÇÑ ¼ö¿ä´Â ´õ¿í µÎµå·¯Áö°í ÀÖÀ¸¸ç, ÀÌ·¯ÇÑ ½É°¢ÇÑ °Ç° ¹®Á¦¸¦ ´Ù·ç´Â »ç¶÷µéÀÇ ¶óÀÌÇÁ¶óÀÎ ¿ªÇÒÀ» Çϰí ÀÖ½À´Ï´Ù. ¸¸¼º ÁúȯÀÇ À¯º´·ü Áõ°¡´Â ¼öÇ÷ÀÌ ÇÊ¿äÇÑ »ç¶÷µé¿¡°Ô ÇʼöÀûÀÎ Ä¡·á ¹× Áö¿øÀ» Á¦°øÇÏ°í ±Ã±ØÀûÀ¸·Î °Ç° °ü¸® ÁöÇ¥ °³¼±¿¡ ±â¿©ÇÏ´Â µ¥ Áß¿äÇÑ ¿ªÇÒÀ» °Á¶ÇÕ´Ï´Ù.
¼öÇ÷ ½ÃÀå¿¡¼ Becton Dickinson(BD)Àº °æÀï ¾÷ü Áß ÃÖ°í ÁöÀ§¸¦ È®º¸Çß½À´Ï´Ù. BD´Â ÆßÇÁ½Ä°ú Áß·Â½Ä ¸ðµÎ¿¡¼ »ç¿ëÇÒ ¼ö ÀÖ´Â Á¾ÇÕÀûÀÎ ¼öÇ÷ ¼¼Æ®¸¦ Á¦°øÇß½À´Ï´Ù. ÀÌ ¼¼Æ®¿¡´Â 180¥ìm ÇÊÅÍ, ¾Ð·Â ÆßÇÁ, ¹Ù´Ã ¾ø´Â Ä¿³ØÅÍ, ¼öÇü ·ç¾î¶ô ¾î´ðÅÍ¿Í °°Àº Çʼö ±¸¼ºÇ°ÀÌ Æ÷ÇԵǾî ÀÖ¾ú½À´Ï´Ù. ÀÌ ¼¼Æ®´Â BDÀÇ Alaris ºê·£µå ¼ö¾× ÆßÇÁ¿Í ÇÔ²² »ç¿ëÇϵµ·Ï Ưº°È÷ ¼³°èµÇ¾ú½À´Ï´Ù.
Baxter´Â ¼öÇ÷ ½ÃÀå¿¡¼ µÎ ¹øÂ° ÀÚ¸®¿¡ ÀÖ½À´Ï´Ù. ÀÌ È¸»ç´Â Ç¥ÁØ Ç÷¾× ÀζóÀÎ ÇÊÅÍ, Y-»çÀÌÆ®, Ç¥ÁØ ¼öÇü ·ç¾î Ä¿³ØÅÍ, ¾Ð·Â ÆßÇÁ µî ´Ù¾çÇÑ Ç÷¾× ¼öÁý ¹× Åõ¿© ¼¼Æ®¸¦ Á¦°øÇß½À´Ï´Ù. Baxter´Â ¼ö¾×¼¼Æ®¿Í ¼ö¾×ÆßÇÁ ½ÃÀå ¸ðµÎ¿¡¼ È®°íÇÑ ÁöÀ§¸¦ ±¸ÃàÇϰí ÀÖ¾î Ç÷¾×¼¼Æ® ÆÇ¸Å¸¦ È¿°úÀûÀ¸·Î ÃßÁøÇÒ ¼ö ÀÖ¾ú½À´Ï´Ù. ÀÌ ±â¾÷ÀÇ Á¦Ç° ¶óÀξ÷¿¡´Â µà¾ó è¹ö À¯Çü°ú ½Ì±Û è¹ö À¯ÇüÀÌ ÀÖ½À´Ï´Ù.
¼öÇ÷ ½ÃÀå¿¡¼ °æÀï»ç Áß 3À§ÀÎ ICU MedicalÀº ºÏ¹Ì¿¡¼ ƯÈ÷ ÈûÀ» ¹ßÈÖÇß½À´Ï´Ù. ÀÌ È¸»ç´Â ¼öÇ÷ Ä¡·á Æ÷Æ®Æú¸®¿À¿¡¼ ±¤¹üÀ§ÇÑ Á¦Ç°°ú ÀÏȸ¿ëǰÀ» º¸À¯Çϰí ÀÖ¾úÀ¸¸ç, Smiths Medical Àμö¸¦ ÅëÇØ Æ÷Æ®Æú¸®¿À¸¦ ´õ¿í È®ÀåÇß½À´Ï´Ù. ICU MedicalÀº Áß·Â ÆßÇÁ¿Í ÀÎÇ»Àü ÆßÇÁ ¸ðµÎ¿¡ ȣȯµÇ´Â ¼öÇ÷ ¼¼Æ®¸¦ Á¦°øÇß½À´Ï´Ù. ¶ÇÇÑ Saf-T Wing¢â Á¦Ç° ¶óÀÎÀÇ ÀϺηΠ¼¼ °¡Áö Ç÷¾× ¼öÁý ¹× Åõ¿© Æ©ºê ¿É¼Ç°ú °ü·Ã ¾×¼¼¼¸®¸¦ Á¦°øÇß½À´Ï´Ù.
¼¼°èÀÇ ¼öÇ÷(Blood Transfusion) ½ÃÀåÀ» Á¶»çÇßÀ¸¸ç, ½ÃÀå °³¿ä/ºÎ¹®º°¡¤Áö¿ªº° µ¿Çâ/°æÀï ±¸µµ µî Á¤º¸¸¦ Á¦°øÇÕ´Ï´Ù.
In 2023, the global blood transfusion set market reported a total value of $480.1 million, reflecting a 3.5% decline from the $464.1 million recorded in 2022. However, projections for the upcoming period indicate a positive growth trajectory, with a compound annual growth rate (CAGR) of 3.0%, ultimately reaching $591 million. Currently, the global blood transfusion set market is under the dominion of Becton Dickinson (BD), Baxter, and ICU Medical.
Our comprehensive medical market research encompassed a thorough analysis of more than 15 blood transfusion companies across seven continents. Employing a rigorous methodology, we delved into market sizes, unit sales, company market shares, and generated precise forecasts.
The prevalence of chronic illnesses like cancer, cardiovascular diseases, and blood disorders is on the rise, leading to an increased need for regular blood transfusions as a crucial aspect of treatment. With the growing incidence of these conditions, the demand for blood transfusion kits becomes even more pronounced, serving as a lifeline for individuals grappling with these significant health challenges. The increasing prevalence of chronic diseases underscores the essential role played by blood transfusion kits in providing essential care and support to those in need, ultimately contributing to improved healthcare outcomes.
Becton Dickinson (BD) secured its top position among competitors in the blood transfusion device market. BD offered a comprehensive range of blood IV sets, available in both pump-based and gravity-based configurations. These sets featured essential components such as a 180-µm filter, a pressure pump, a needleless connector, and male Luer lock adapters. They were specifically designed for use with BD's Alaris brand of infusion pumps. BD's presence in the IV set market was substantial, and in 2015, the company bolstered its industry standing by acquiring infusion therapy products from CareFusion.
Baxter held the second spot in the blood transfusion device market. The company provided a diverse array of blood collection and administration sets, including standard blood in-line filters, Y-sites, male Luer lock injection adapters, and a pressure pump. Baxter's robust position in both the IV set and infusion pump markets allowed them to drive sales of blood sets effectively. Their product lineup encompassed dual-chamber and single-chamber devices.
ICU Medical, ranking third among competitors in the blood transfusion device market, demonstrated particular strength in North America. The company boasted an extensive range of products and disposables within its infusion therapy portfolio, which was further expanded through the acquisition of Smiths Medical. ICU Medical offered transfusion sets compatible with both gravity and infusion pumps. Additionally, they provided three distinct blood collection and administration tubing options, along with associated accessories, as part of their Saf-T Wing™ product line.
Blood Transfusion Market